Article
Lymphotoxin-β Interacts with Methylated EGFR to Mediate Acquired Resistance to Cetuximab in Head and Neck Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Aug 2017
Hsu Dennis Shin-Shian, Hwang Wei-Lun, Yuh Chiou-Hwa, Chu Chen-Hsi, Ho Yang-Hui, Chen Pon-Bo, Lin Han-Syuan, Lin Hua-Kuo, Wu Shih-Pei, Lin Chih-Yi, Hsu Wen-Hao, Lan Hsin-Yi, Wang Hsiao-Jung, Tai Shyh-Kuan, Hung Mien-Chie, Yang Muh-Hwa
Abstract excerpt
Purpose: In head and neck squamous cell carcinoma (HNSCC), the incidence of RAS mutation, which is the major cause of cetuximab resistance, is relatively rare compared with the other types of cancers, and the mechanism mediating acquired resistance is unclear compared with the driver gene mutation-mediated de novo resistance. Here, we investigated the driver gene mutation-independent mechanism for cetuximab...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
